<p>Stuart Rich, Chief Medical Officer and Director of Tenax Therapeutics Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenax Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001841785-25-000003), on December 05, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

TENX

<p>Stuart Rich, Chief Medical Officer of Tenax Therapeutics Inc., reported acquiring common shares of the company. This event was disclosed via EDGAR by Tenax Therapeutics on December 05, 2025. The information is for informational purposes and not financial advice.</p>

Tenax Therapeutics Chief Medical Officer Stuart Rich Reports Acquisition of Common Shares